Skip to content

SPECT guided left ventricular lead implantation in cardiac resynchronization therapy

SPECT guided left ventricular lead implantation in cardiac resynchronization therapy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001718
Enrollment
Unknown
Registered
2011-11-15
Start date
2012-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure (CHF)

Interventions

Control:Standard-of-care CRT implantation
Guided:Standard-of-care CRT implantation

Sponsors

First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patient has signed and dated study informed consent. Patient is able to receive pectoral implant. Patient is indicated for either CRT or CRT-D system; 2. Patient has moderate to severe HF (NYHA Class II, III or IV); 3. Patient has LVEF =120 ms; 5. Patient is in sinus rhythm.

Exclusion criteria

Exclusion criteria: 1. Patient has mechanical right heart valve (contraindicated for pacer wire placement); 2. Patient has experienced unstable angina, acute MI, CABG or PCI within the past 3 months; 3. Patient is on continuous or intermittent intravenous inotropic drug therapy; 4. Patient known to have chronic permanent atrial arrhythmias; 5. Patient is enrolled in any concurrent study that would confound the results of this study; 6. Patient has a life expectancy of less than 12 months; 7. Women who are pregnant, or with child-bearing potential and who are not on a form of birth control; 8. Patient with CRT device implanted previously. Patient has had a heart transplant.

Design outcomes

Primary

MeasureTime frame
changes in LVES;

Secondary

MeasureTime frame
CRT response rate;composite clinical response rate;

Countries

China

Contacts

Public ContactCao Kejiang
kjcao@njmu.edu.cn+86 13901599830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026